Parkinson’s disease, metacreams and anxious and depressive symptoms

The work of Dr. Viviana Cereda, Giulia Anchora, Marta Fanfoni and Cristina Ferretti was presented at the Psychotherapy Research Forum under the title “Metacreams and cognitive processes influence depressive and anxious symptoms in Parkinson’s disease“.

Announcements There Parkinson’s disease (MP) is a slow and progressive neurodegenerative disease with a multifactorial etiology. It is characterized by motor symptoms, tremors that begin at rest, bradykinesia, and muscle stiffness, and nonmotor symptoms, including vegetative disorders, cognitive deficits, depression, and anxiety, which are the focus of the study presented.

Depression and anxiety in Parkinson’s disease

Depression is present in approximately 40% of patients with Parkinson’s diseaseAlthough the diagnosis is complicated by the fact that several typical symptoms of depression, such as fatigue, insomnia, changes in appetite, alexithymia, and psychomotor slowing, overlap with symptoms of Parkinson’s disease. Even with regard to anxiety, the incidence is high, as it occurs in 30% of patients. The most common anxiety disorders in Parkinson’s disease are generalized anxiety, panic attacks, and phobias.

Anxiety and depressive symptoms can occur at different stages of the disease: they can be prodromal, therefore prior to the onset of motor symptoms, reactive to diagnosis, or they can appear throughout the disease.

Anxiety and depression are associated with a worse prognosis. One area of ​​research that has not yet been fully understood is that which investigates the impact of psychological processes, such as rumination and parenting, on the symptoms of these patients.

The study presented was based on the theoretical formulation of Adrian Wells, founder of Metacognitive Therapy (MCT), who placed metacognition, or thought applied to thought, that monitors, controls, and evaluates the process and product at the center. of its model. consciousness, placing as central to affective disorders the presence of a persevering and ubiquitous thought called Attentive Cognitive Syndrome (SAC).

Parkinson’s disease and metacreves: the study

Announcements The research presented investigated the Parkinson’s disease the relationship between depressive and anxious symptoms, the processes of ruminating and meditating, and metacreations, based on two fundamental hypotheses: depressive symptoms in Parkinson’s disease are associated with the presence of metacreactions and ruminant processes, and symptoms of anxiety in Parkinson’s disease are associated with the presence of metacrexes and ruminant processes. The ultimate goal of the study was to correctly frame the affective symptoms characterized by cognitive components in the Parkinson’s diseasewithin clinical practice.

An observational, correlational, and multicenter study was performed in which subjects compiled a battery of tests that included BDI-II, BAI, RRS, PSWQ, MCQ-30. Descriptive, correlational, and multiple regression analyzes were then performed.

A positive association arose between metacreactions, processes (rumination, and caving), and anxiety-depressive symptoms, with a strong influence of negative metacrevices on affective symptoms.

Given the prevalence of depression and anxiety a Parkinson’s disease it is useful to reflect on the relationship between symptoms, metacreams, and rumination. This is the first study to examine the role of affective processes, metacreams, and symptoms Parkinson’s disease. The predominant role of CAS in the aggravation and maintenance of depressive and anxious symptoms emerges, thus opening up to the possible use of a new CBT protocol on affective symptoms in Parkinson’s diseaseincluding the treatment of processes and metacreams, such as metacognitive therapy.

In summary, this study showed a strong correlation between depressive and anxious symptoms and negative metacreactions. The cognitive components of these mood disorders characterize the severity of the symptoms themselves and can therefore become the main focus of cognitive-behavioral treatment. In order to reduce the depressive and anxious symptoms in the Parkinson’s diseaseit might be helpful to develop a specific protocol on the processes and metacrevents associated with depressive and anxiety characteristics.

Recommended by publishers

State of Mind © 2011-2022 All rights reserved.

Images (from top to bottom) of:

Leave a Comment